Prospective evaluation of the thrombotic risk in children with all carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant and further prothrombotic risk factors.

被引：0
|
作者：
Nowak-Göttl, U
Wermes, C
Junker, R
Schobess, R
Fleischhack, G
Schwabe, D
机构：
[1] Univ Hosp, Bonn, Germany
[2] Univ Hosp, Frankfurt, Germany
[3] Univ Hosp, Halle, Germany
[4] Univ Hosp, Hannover, Germany
[5] Univ Hosp, Munster, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
337
引用
收藏
页码：83A / 83A
页数：1
相关论文
共 29 条
  • [21] Prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) mutations are risk factors for pulmonary embolism: Initial findings from the thrombosis and genes (TAG) cohort study.
    Dilley, A
    Hooper, WC
    El-Jamil, M
    Evatt, B
    BLOOD, 2001, 98 (11) : 264A - 264A
  • [22] Molecular risk factors (FV Leiden, C677T MTHFR, G20210A Pro-thrombin) in patients with arterial and venous thrombosis from Argentine
    Altman, R
    Schröder, W
    Grimm, W
    Schuster, R
    Herrmann, G
    THROMBOSIS AND HAEMOSTASIS, 1999, : 190 - 190
  • [23] Prevalence of genetic prothrombotic risk factors: 1691G>A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population
    Adler, Grazyna
    Agnieszka, Garstka
    Valjevac, Amina
    Czerska, Ewa
    Kiseljakovic, Emina
    Salkic, Nermin Nusret
    ANNALS OF HUMAN BIOLOGY, 2015, 42 (06) : 576 - 580
  • [24] Risk of recurrence in children carrying the single heterozygous factor V G1691A mutation or the factor II G20210A variant - No need for a prolonged antithrombotic therapy.
    Heller, C
    Junker, R
    Kosch, A
    Kurnik, K
    Schobess, R
    Nowak-Gottl, U
    BLOOD, 2002, 100 (11) : 701A - 702A
  • [25] MTHFR C677T, PROTHROMBIN G20210A AND JAK2 V617F MUTATIONS ARE ASSOCIATED WITH INCREASED RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH CHRONIC LIVER DISEASE
    Maras, Jaswinder S.
    Garg, Vishal
    Sarin, Shiv K.
    HEPATOLOGY, 2010, 52 (04) : 904A - 904A
  • [26] Evaluation of the glycoprotein 1A (GP1a) 807TT, the methylene tetrahydrofolate reductase (MTHFR) 677TT, and the prothrombin 20210GA genotypes as cooperative risk factors for venous thrombosis among factor V 1691GA (Leiden) carriers.
    Hessner, MJ
    Dinauer, DM
    Luhm, RA
    Endres, JL
    Montgomery, RR
    Friedman, KD
    BLOOD, 1998, 92 (10) : 304A - 304A
  • [27] Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey
    Oztuzcu, Serdar
    Ergun, Sercan
    Ulasli, Mustafa
    Nacarkahya, Gulper
    Igci, Yusuf Ziya
    Igci, Mehri
    Bayraktar, Recep
    Tamer, Ali
    Cakmak, Ecir Ali
    Arslan, Ahmet
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (06) : 3671 - 3676
  • [28] Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey
    Serdar Oztuzcu
    Sercan Ergun
    Mustafa Ulaşlı
    Gülper Nacarkahya
    Yusuf Ziya Iğci
    Mehri Iğci
    Recep Bayraktar
    Ali Tamer
    Ecir Ali Çakmak
    Ahmet Arslan
    Molecular Biology Reports, 2014, 41 : 3671 - 3676
  • [29] Contraception-Related Deep Venous Thrombosis and Pulmonary Embolism in a 17-Year-Old Girl Heterozygous for Factor V Leiden, Prothrombin G20210A Mutation, MTHFR C677T and Homozygous for PAI-1 Mutation: Report of a Family with Multiple Genetic Risk Factors and Review of the Literature
    Krleza, Jasna Lenicek
    Jakovljevic, Gordana
    Bronic, Ana
    Herak, Desiree Coen
    Bonevski, Aleksandra
    Stepan-Giljevic, Jasminka
    Roic, Goran
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2009, 37 (01) : 24 - 29
123